References:

[1]国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2015.
[2]姜泽群,李育,江励华,等.制山茱萸活性部位对D半乳糖致小鼠肝损伤的保护作用[J].中药材,2013,36(1):85-89.
[3]张亚军,高云艳.山茱萸化学成分与药理研究概况[J].中国中医药信息杂志,2002,9(10):81-82.
[4]Sousa JN,Paraíso AF,Andrade JMO,et al.Oral gallic acid improve liver steatosis and metabolism modulating hepatic lipogenic markers in obese mice[J].Experimental Gerontology,2020,134.
[5]李光燮,朴成哲.山茱萸总苷对四氯化碳诱导的急性肝损伤的影响[J].山东医药,2011,51(20):43-44.
[6]郑雪花,杨君,杨跃辉.没食子酸药理作用的研究进展[J].中国医院药学杂志,2017,37(1):94-98.
[7]孙晓梅,阎姝,田书霞.中药抗肝损伤的研究进展[J].中药材,2016,39(11):2661-2664.
[8]于歆,李晓冰,何晓静,等.药物性肝损伤的机制[J].中国医院药学杂志,2017,37(10):895-899.
[9]吕舰,张洪,王丽.肝纤维化分子机制及治疗研究进展[J].中国医院药学杂志,2017,37(18):1873-1876.
[10]解静,高杉,李琳,等.网络药理学在中药领域中的研究进展与应用策略[J].中草药,2019,50(10):2257-2265.
[11]宗阳,董宏利,陈婷,等.基于网络药理学黄芩黄连药对治疗2型糖尿病作用机制探讨[J].中草药,2019,50(4):888-894.
[12]Liu H,Zeng L,Yang K,et al.A network pharmacology approach to explore the pharmacological mechanism of xiaoyao powder on anovulatory infertility[J].EvidenceBased Complementary and Alternative Medicine,2016.
[13]Yang L,Liu W,Hu Z,et al.A systems pharmacology approach for identifying the multiple mechanisms of action of the wei pi xiao decoction for the treatment of gastric precancerous lesions[J].EvidenceBased Complementary and Alternative Medicine,2019.
[14]Huang J,Tang H,Cao S,et al.Molecular targets and associated potential pathways of danlu capsules in hyperplasia of mammary glands based on systems pharmacology[J].EvidenceBased Complementary and Alternative Medicine,2017.
[15]Stanstrup J,Broeckling CD,Helmus R,et al.The metaRbolomics Toolbox in Bioconductor and beyond[J].Metabolites,2019,9(10):200.
[16]Hsia C,Ho M,Shui H,et al.Analysis of dermal papilla cell interactome using STRING database to profile the ex vivo hair growth inhibition effect of a vinca alkaloid drug,colchicine[J].International journal of molecular sciences,2015,16(2):3579-3598.
[17]王世伟,徐宁.山茱萸环烯醚萜总苷对小鼠胰岛素抵抗和非酒精性肝损伤的改善作用及其机制研究[J].天津中医药,2017,34(3):195199.
[18]Rao SN,Head MS,Kulkarni A,et al.Validation studies of the sitedirected docking program LibDock[J].Journal of chemical information and modeling,2007,47(6):2159-2171.
[19]李光燮,朴成哲.山茱萸总苷对四氯化碳诱导的急性肝损伤的影响[J].山东医药,2011,51(20):43-44.
[20]陈玉霞,刘建华,林峰,等.DPPH和FRAP法测定41种中草药抗氧化活性[J].实验室研究与探索,2011,30(6):11-14.
[21]杨学东,丁小军.山茱萸属植物化学成分和药理活性研究进展[J].时珍国医国药,2007,18(9):2284-2286.
[22]赵晨翔,张雅敏,刘宏胜,等.山茱萸总苷对小鼠免疫性肝损伤治疗作用的初步研究[J].天津中医药,2017,34(2):120-124.
[23]周玉燕,孙玉,李萍,等.莫诺苷通过抗氧化应激保护雷公藤甲素所致肝细胞凋亡[J].南方医科大学学报,2018,38(8):949-955.
[24]E U M,L R M,K G A,et al.PIK3R1(p85α)is somatically mutated at high frequency in primary endometrial cancer[J].Cancer research,2011,71(12).
[25]KaidarPerson O,Zagar TM,Deal A,et al.The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases:the potential impact of immunotherapy[J].Anticancer drugs,2017,28(6):669-675.
[26]Y X,S Z,Q L,et al.miR219a5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2[J].Digestive diseases and sciences,2019,64(8):2177-2186.
[27]C T,B H,K Z,et al.The transcription factor cJUN/AP1 promotes HBVrelated liver tumorigenesis in mice[J].Cell death and differentiation,2016,23(4):576-582.
[28]Nme A E,Do S,Ss M,et al.Olmesartan attenuates type 2 diabetesassociated liver injury:Crosstalk of AGE/RAGE/JNK,STAT3/SCOS3 and RAS signaling pathways[J].European journal of pharmacology,2020,874:173010.
[29]Annie Z,Jaganathan L,Amirreza M,et al.MicroRNA203 suppresses proliferation in liver cancer associated with PIK3CA,p38 MAPK,cJun,and GSK3 signaling[J].Molecular and cellular biochemistry,2018,441(1-2).
[30]Q M,Le C,Hj L,et al.A role for virally induced reactive oxygen species in Kaposis sarcoma herpesvirus tumorigenesis.[J].Antioxidants & redox signaling,2013,18(1):80-90.

Memo

基金项目:陕西省教育厅重点科研计划项目(18JS028);陕西中医药大学学科创新团队项目(2019-YL12)

Last Update: 2022-07-25
Copyright @ 2020 Journal of Shaanxi University of Chinese Medicine
 Address: Middle Section of Century Avenue, Xianyang, Shaanxi Province. Post Code: 712046
Tel: 029-38185250 Fax: 029-38185250 E-mail: shxzhzs@163.com Powered by: www.editorhome.cn